In Vivo Emergence of UL56 C325Y Cytomegalovirus Resistance to Letermovir in a Patient with Acute Myeloid Leukemia after Hematopoietic Cell Transplantation

CMV associated tissue-invasive disease is associated with a considerable risk of morbidity and mortality after allogeneic hematopoietic stem cell transplantation (HSCT). Recently, the terminase inhibitor letermovir (LMV) has been approved for prophylaxis of CMV infection in HSCT. We hereby report a...

詳細記述

書誌詳細

主要な著者:	Jochen J Frietsch, Detlef Michel, Thomas Stamminger, Friederike Hunstig, Sebastian Birndt, Ulf Schnetzke, Sebastian Scholl, Andreas Hochhaus, Inken Hilgendorf
フォーマット:	Artigo
言語:	Inglês
出版事項:	PAGEPress Publications 2019-01-01
シリーズ:	Mediterranean Journal of Hematology and Infectious Diseases
主題:	Cytomegalovirus hematopoietic stem cell transplantation reactivation letermovir
オンライン･アクセス:	https://www.mjhid.org/index.php/mjhid/article/view/3708
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!